Compare CADL & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | HCKT |
|---|---|---|
| Founded | 1999 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.4M | 324.6M |
| IPO Year | 2021 | 1998 |
| Metric | CADL | HCKT |
|---|---|---|
| Price | $6.20 | $13.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $19.00 | $17.00 |
| AVG Volume (30 Days) | ★ 1.7M | 217.4K |
| Earning Date | 05-14-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.73% |
| EPS Growth | ★ 58.62 | N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | $125,000.00 | ★ $285,862,000.00 |
| Revenue This Year | N/A | $2.55 |
| Revenue Next Year | N/A | $5.07 |
| P/E Ratio | ★ N/A | $28.05 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.34 | $12.19 |
| 52 Week High | $7.66 | $26.74 |
| Indicator | CADL | HCKT |
|---|---|---|
| Relative Strength Index (RSI) | 56.36 | 45.96 |
| Support Level | $5.42 | $12.42 |
| Resistance Level | $6.41 | $14.67 |
| Average True Range (ATR) | 0.48 | 0.52 |
| MACD | 0.09 | 0.00 |
| Stochastic Oscillator | 49.22 | 34.88 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.